XELJANZ
Why is PFE stock falling today despite beating Pfizer's earnings estimates? Key factors investors are watching
TrumpRx website 2025: direct-to-consumer prescription drug platform and Pfizer discount deal explained
Over 250 medicines to cost more from January 1 in the U.S; is your critical drug in the list? Check here
Zydus Cadila gets tentative USFDA nod for generic drugThe company has received tentative approval from the US Food and Drug Administration (USFDA) for the product which is the generic version o...19 Oct, 2020, 12.55 PM IST
Pfizer’s patent claim for Xeljanz dismissedThe base compound of the drug has been granted patents in India and Pfizer attempted to secure additional patents for the follow-up improve...07 Sep, 2015, 04.45 PM IST
Load More